Home / Combinations / GHK-Cu + Argireline
CombinationSkin & JointAnti-AgingEmerging evidence
GHK-Cu + Argireline
Skin Rejuvenation & Line Reduction
GHK-Cu is a naturally occurring copper-binding tripeptide associated with collagen and elastin synthesis, antioxidant gene activation, and skin tissue remodeling. Argireline (acetyl hexapeptide-3) is researched for inhibiting neurotransmitter-mediated facial muscle contraction to reduce expression-line appearance. Together they address skin aging through complementary structural and neuromuscular pathways.
Stack components
GHK-CuCompound 01
ArgirelineCompound 02
2
Compounds
2
Sources on file
6
Providers carry all
Mechanism
What each compound is researched for on its own. Nothing here describes an interaction between them.
Compound 01
GHK-Cu
Copper-binding tripeptide researched for stimulating collagen and elastin production, activating antioxidant genes, and supporting overall skin tissue remodeling and repair.
Compound 02
Argireline
Acetyl hexapeptide-3 researched for inhibiting SNARE-complex-mediated neurotransmitter release at facial muscle junctions to reduce expression-related wrinkle depth.
Composition
2 compounds · 2 research areas
Stated as recorded. This page describes each compound separately and makes no claim that they act together.
Safety notes
Both peptides have extensive cosmetic and dermatological research records. GHK-Cu has a well-characterized safety profile across topical, injectable, and intranasal delivery forms. Argireline is widely used in commercial cosmeceuticals and is among the better-studied cosmetic peptides.
Author-written. Not derived from any compound field, and not covered by the profile-integrity audit that gates the peptide pages.
Research references2 sources
Moderate
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Int J Mol Sci 2018
PeptideBase notePer-component source only — no combination study exists
Moderate
Skin anti-aging strategies
Dermatoendocrinol 2012
PeptideBase noteReviews cosmetic peptides including argireline — no combination study exists
Related combinations3 share an area
Educational use only
PeptideBase documents what compounds are researched together and what evidence exists for each one separately. It does not provide medical advice, diagnosis, treatment, prescribing guidance or dosing instructions. Last reviewed 23 Apr 2026.
PeptideBase documents what compounds are researched together and what evidence exists for each one separately. It does not provide medical advice, diagnosis, treatment, prescribing guidance or dosing instructions. Last reviewed 23 Apr 2026.